01
What it usually means
What longevity peptides usually means
The phrase may include growth hormone secretagogues, mitochondrial peptides such as MOTS-c, cellular energy therapies such as NAD+, skin-related peptides such as GHK-Cu, and experimental bioregulators. These are very different categories.
02
Outcomes vs. markers
Separate outcomes from markers
Better sleep, body composition, glucose markers, inflammation markers, energy, and skin appearance may matter to patients. But those are not the same as proving longevity. Good longevity content should name the difference.
Moving a biomarker is not the same as adding healthy years. The two get conflated in marketing, almost never in clinical literature.
03
Foundations dominate
Foundations still dominate
- Blood pressure and lipids.
- Resistance training and aerobic fitness.
- Sleep and circadian rhythm.
- Protein, fiber, and energy balance.
- Smoking, alcohol, and preventive screening.
04
Where peptides may fit
Where peptides may fit
Peptide therapy may be considered when a specific goal, risk profile, and monitoring plan exist. It should not replace primary care, preventive cardiometabolic care, cancer screening, or evidence-based treatment for diagnosed disease.
05
Provider questions
Provider questions
- What measurable outcome are we targeting?
- Is this supported by human outcome data or mostly mechanism?
- What labs or symptoms are we monitoring?
- What would make this therapy inappropriate for me?
Sources